These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38654668)

  • 1. Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia.
    Ruan GJ; Wu X; Gwin KA; Manske MK; Abeykoon JP; Bhardwaj V; Witter TL; Schellenberg MJ; Rabe KG; Kay NE; Parikh SA; Witzig TE
    Haematologica; 2024 Sep; 109(9):2884-2892. PubMed ID: 38654668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 ORF8 Mediates Signals in Macrophages and Monocytes through MyD88 Independently of the IL-17 Receptor.
    Ponde NO; Shoger KE; Khatun MS; Sarkar MK; Dey I; Taylor TC; Cisney RN; Arunkumar SP; Gudjonsson JE; Kolls JK; Gottschalk RA; Gaffen SL
    J Immunol; 2023 Jul; 211(2):252-260. PubMed ID: 37265402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.
    Wu X; Xia T; Shin WJ; Yu KM; Jung W; Herrmann A; Foo SS; Chen W; Zhang P; Lee JS; Poo H; Comhair SAA; Jehi L; Choi YK; Ensser A; Jung JU
    mBio; 2022 Apr; 13(2):e0040222. PubMed ID: 35343786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm.
    Hamdorf M; Imhof T; Bailey-Elkin B; Betz J; Theobald SJ; Simonis A; Di Cristanziano V; Gieselmann L; Dewald F; Lehmann C; Augustin M; Klein F; Alejandre Alcazar MA; Rongisch R; Fabri M; Rybniker J; Goebel H; Stetefeld J; Brachvogel B; Cursiefen C; Koch M; Bock F
    J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37891014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Blood Mononuclear Cells and Serum Cytokines in Patients with Lupus Nephritis after COVID-19.
    Lisowska KA; Ciesielska-Figlon K; Komorniczak M; Bułło-Piontecka B; Dębska-Ślizień A; Wardowska A
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses.
    Kohyama M; Suzuki T; Nakai W; Ono C; Matsuoka S; Iwatani K; Liu Y; Sakai Y; Nakagawa A; Tomii K; Ohmura K; Okada M; Matsuura Y; Ohshima S; Maeda Y; Okamoto T; Arase H
    Int Immunol; 2023 Jan; 35(1):43-52. PubMed ID: 36053553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
    Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD
    Front Immunol; 2021; 12():679482. PubMed ID: 34177923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.
    Móvio MI; Almeida GWC; Martines IDGL; Barros de Lima G; Sasaki SD; Kihara AH; Poole E; Nevels M; Carlan da Silva MC
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
    Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
    Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal Structures of Bat and Human Coronavirus ORF8 Protein Ig-Like Domain Provide Insights Into the Diversity of Immune Responses.
    Chen X; Zhou Z; Huang C; Zhou Z; Kang S; Huang Z; Jiang G; Hong Z; Chen Q; Yang M; He S; Liu S; Chen J; Li K; Li X; Liao J; Chen J; Chen S
    Front Immunol; 2021; 12():807134. PubMed ID: 34975921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals.
    Ostapchuk YO; Lushova AV; Kan SA; Abdolla N; Kali A; Tleulieva R; Perfilyeva AV; Perfilyeva YV
    Infect Immun; 2024 Jul; 92(7):e0021624. PubMed ID: 38874358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity.
    Beaudoin-Bussières G; Arduini A; Bourassa C; Medjahed H; Gendron-Lepage G; Richard J; Pan Q; Wang Z; Liang C; Finzi A
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Damery S; Tyson G; Logan N; Davis C; Willett B; Zuo J; Ali M; Kaur M; Stephens C; Brant D; Otter A; McSkeane T; Rolfe H; Faustini S; Richter A; Lee S; Wandroo F; Shafeek S; Pratt G; Paneesha S; Moss P
    J Hematol Oncol; 2022 Jan; 15(1):3. PubMed ID: 35000597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
    Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
    Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted ORF8 induces monocytic pro-inflammatory cytokines through NLRP3 pathways in patients with severe COVID-19.
    Wu X; Manske MK; Ruan GJ; Witter TL; Nowakowski KE; Abeykoon JP; Tang X; Yu Y; Gwin KA; Wu A; Taupin V; Bhardwaj V; Paludo J; Dasari S; Dong H; Ansell SM; Badley AD; Schellenberg MJ; Witzig TE
    iScience; 2023 Jun; 26(6):106929. PubMed ID: 37260746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.
    Blanco G; Puiggros A; Sherry B; Nonell L; Calvo X; Puigdecanet E; Chiu PY; Kieso Y; Ferrer G; Palacios F; Arnal M; Rodríguez-Rivera M; Gimeno E; Abella E; Rai KR; Abrisqueta P; Bosch F; Calon A; Ferrer A; Chiorazzi N; Espinet B
    Exp Hematol; 2021 Mar; 95():68-80. PubMed ID: 33421548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate Diagnosis of COVID-19 by a Novel Immunogenic Secreted SARS-CoV-2 orf8 Protein.
    Wang X; Lam JY; Wong WM; Yuen CK; Cai JP; Au SW; Chan JF; To KKW; Kok KH; Yuen KY
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
    Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
    Front Immunol; 2021; 12():627548. PubMed ID: 33777012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.